Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch 
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment 
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised 
Washington Post Publisher Will Lewis Steps Down After Layoffs 
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans 
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings 
Ford and Geely Explore Strategic Manufacturing Partnership in Europe 
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering 
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing 
Instagram Outage Disrupts Thousands of U.S. Users 
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off 
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape 
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning 
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit 
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine 
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences 
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies 
MOORESTOWN, N.J., Nov. 01, 2016 -- Tabula Rasa HealthCare (NASDAQ:TRHC) announced today its Chairman and CEO Calvin H. Knowlton, PhD, has been named a finalist by SmartCEO magazine for its 2016 Circle of Excellence – Technology Award. The Award “recognizes the region’s most accomplished CEOs for business excellence”.
According to SmartCEO, companies are nominated from all size and industry categories, public and private. An independent committee of business leaders selects the winners based on “industry impact, innovation and market leadership”.
“Tabula Rasa HealthCare is devoted to leveraging technology to improve health care,” said Knowlton. “We are at the forefront of precision medicine with solutions that help clients tailor medical treatment to the individual characteristics of each patient. Our cloud-based software applications are designed to identify high-risk individuals, detect susceptibility to adverse drug events (ADEs) and embed proper dosing guidelines.”
TRHC products and services are built around the Company’s proprietary Medication Risk Mitigation Matrix® and other software applications that provide solutions for a range of payors, providers and healthcare organizations. TRHC is the market leader in providing medication risk management, risk adjustment and front-end coding for the Program of All-Inclusive Care for the Elderly (PACE), as well as a leader in pharmacy cost management solutions.
Finalists will be profiled in the November/December issue of SmartCEO magazine. The winners are celebrated at a gala event November 9, 2016 in Philadelphia.
About Tabula Rasa HealthCare
Tabula Rasa HealthCare (NASDAQ:TRHC) is a leader in providing patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations, lower healthcare costs and manage risk. Medication risk management is TRHC’s lead offering, and its cloud-based software applications provide solutions for a range of payers, providers and other healthcare organizations. For more information, please visit: www.TRHC.com.
Contact: Media Dianne Semingson [email protected] T: 215-870-0829 Investors Bob East or Asher Dewhurst Westwicke Partners 443-213-0500 [email protected]
